Precipio Net Change in Property, Plant, and Equipment 2010-2025 | PRPO

Precipio net change in property, plant, and equipment from 2010 to 2025. Net change in property, plant, and equipment can be defined as the overall change in capital expenditures and sales of plant, property and equipment. This field is used if a company does not report separately sales and purchases of plant, property and equipment or is calculated as the sum of purchases and sales of PP&E
Precipio Annual Net Change in Property, Plant, and Equipment
(Millions of US $)
2024 $0
2023 $0
2022 $0
2021 $-1
2020 $0
2019 $0
2018 $0
2017 $0
2016 $N/A
2015 $0
2014 $0
2013 $-1
2012 $-1
2011 $0
2010 $0
2009 $0
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.015B $0.019B
Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. Precipio Inc., formerly known as Transgenomic Inc., is based in Omaha, United States of America.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.320B 52.93
Hims & Hers Health (HIMS) United States $11.979B 124.46
Tempus AI (TEM) United States $10.204B 0.00
IRhythm Technologies (IRTC) United States $4.547B 0.00
Inspire Medical Systems (INSP) United States $4.305B 67.26
Privia Health (PRVA) United States $2.816B 192.50
Enovis (ENOV) United States $1.849B 10.31
Clover Health Investments (CLOV) United States $1.669B 0.00
Schrodinger (SDGR) United States $1.550B 0.00
Phreesia (PHR) United States $1.447B 0.00
Omnicell (OMCL) United States $1.351B 23.83
Azenta (AZTA) United States $1.283B 59.64
10x Genomics (TXG) United States $1.052B 0.00
Fulgent Genetics (FLGT) United States $0.625B 0.00
Butterfly Network (BFLY) United States $0.529B 0.00
Claritev (CTEV) United States $0.479B 0.00
Veradigm (MDRX) United States $0.476B 0.00
Talkspace (TALK) United States $0.462B 138.00
Standard BioTools (LAB) United States $0.363B 0.00
TruBridge (TBRG) United States $0.356B 789.67
Outset Medical (OM) United States $0.327B 0.00
Nyxoah SA (NYXH) Belgium $0.283B 0.00
Health Catalyst (HCAT) United States $0.254B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.193B 0.00
EUDA Health Holdings (EUDA) Singapore $0.136B 0.00
Pulmonx (LUNG) United States $0.126B 0.00
American Well (AMWL) United States $0.116B 0.00
MDxHealth SA (MDXH) Belgium $0.097B 0.00
CareCloud (CCLD) United States $0.087B 3.31
111 (YI) China $0.067B 0.00
P3 Health Partners (PIII) United States $0.055B 0.00
HeartBeam (BEAT) United States $0.054B 0.00
Retrieve Medical Holdings (RMHI) United States $0.051B 0.00
Zepp Health (ZEPP) Netherlands $0.037B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
MSP Recovery (MSPR) United States $0.011B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Streamline Health Solutions (STRM) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
Movano (MOVE) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00